Description

Nobivac® Intra-Trac®3 vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. Duration of Immunity (DOI) has been demonstrated to be at least one year for Bordetella bronchiseptica.

Benefits

• Requires only single-nostril administration
• Provides protection as early as 48 hours post-vaccination
• Provides 1-year duration of immunity

Dosage and Administration

• DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS

Put 1 ml into one nostril, or split dose between both nostrils. For small dogs and puppies, a 0.5 ml dose may be prepared by mixing 0.5 ml diluent with standard, full dose of powder. Annual revaccination is recommended. Requires mixing. Applicator tips are included. Order syringes separately.

---

by Merck

Nobivac® Intra-Trac®3

Canine Adenovirus Type 2, Parainfluenza, Bordetella Bronchiseptica Vaccine, MODIFIED LIVE VIRUS, AVIRULENT LIVE CULTURE 

Nobivac® Intra-Trac®3 vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. Duration of Immunity (DOI) has been demonstrated to be at least one year for Bordetella bronchiseptica.

Features and benefits 

• Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2
• Offers the superior benefits of intranasal administration
• Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
• Requires only single-nostril administration—low dose of 0.5 mL
• Provides rapid protection as early as 48 hours post-vaccination1*
• Provides 1-year duration of immunity 2

Indication

• Approved for the vaccination of healthy dogs as an aid in prevention of infectious disease associated with canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica infection
• Recommended for use in healthy dogs 3 weeks of age or older

Administration and Dosage

• DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS
• Flexible dosing – For one 1 mL dose, rehydrate vaccine with 1 mL sterile diluent or for one 0.5 mL dose, rehydrate vaccine with 0.5 mL sterile diluent.
• Annual revaccination with 1 dose is recommended

Bordetella + Adenovirus + Parainfluenza Modified live + avirulent live Bordetella bronchiseptica. For protection against canine adenovirus type 2, parainfluenza and Bordetella bronchiseptica. For dogs 3 weeks of age or older. Give intranasally. Instill 1 ml into one nostril, or split dose between both nostrils. For small dogs and puppies, a 0.5 ml dose may be prepared by mixing 0.5 ml diluent with standard, full dose of powder. Annual revaccination is recommended. Requires mixing. Applicator tips are included. Order syringes separately.

---

Vaccines are shipped in a styrofoam cooler with ice packs on Monday-Thursdays (on orders placed before 2:00pm Central Time) 

Click here for our Vaccine Shipping Schedule.

Other Nobivac Canine products available. Call 1-800-934-9398.